Published in Vaccine Weekly, September 11th, 1995
Research presented at the 1994 International Symposium on Cancer Vaccines (H. Bueler et al.) suggested that enhanced tumor antigen presentation and/or T-cell stimulation were potential major pathways involved in the induction of systemic anti-tumor immunity. Accordingly, in situations with known tumor antigens, it could be feasible to generate efficient antitumor vaccines by introducing relevant antigens into host antigen presenting cells (APCs).
Bijay Mukherji et al. hypothesized that cultured...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly